兴奋剂药物的使用和明显皮质厚度的发展在注意力缺陷/多动障碍:一个前性的纵向研究
Zarah van der Pal1, Kristine B Walhovd2,3, Inge K Amlien2,3
1Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center (UMC) location University of Amsterdam, Amsterdam, Netherlands.
对注意力缺陷/多动障碍 (ADHD) 的长期兴奋剂药物治疗没有影响青少年或成年人明显皮质厚度的发展. 观察到的皮层厚度变化与典型的大脑发育模式一致.
科学领域:
- 神经科学是一个神经科学.
- 发展心理学 发展心理学
- 精神病学是一个精神病学.
背景情况:
- 兴奋剂药物是注意力缺陷/多动症 (ADHD) 的常见治疗方法.
- 以前的研究表明,短期使用兴奋剂会以年龄相关的方式影响表面皮质厚度的发展.
- 这些影响是否持续到成年后仍未得到研究.
研究的目的:
- 研究兴奋剂药物对表面皮层厚度发展的长期,年龄相关影响.
- 在被诊断患有多动症的青少年和成年人群中检查这些影响.
主要方法:
- 具有4年后续的前性研究 (ePOD-MPH项目).
- 在预定义的感兴趣区域 (ROI) 中,分析了T1加权的MRI扫描以检测表面皮质厚度.
- 线性混合模型评估了药物使用,时间和年龄组之间对皮质厚度的相互作用.
主要成果:
- 没有证据表明长期兴奋剂药物对区域表面皮质厚度的影响.
- 显著的年龄-时间相互作用证实了青少年明显皮质厚度的预期减少.
- 随着时间的推移,ADHD和焦虑症状减少;较大的ADHD症状改善与成人更高的药物使用相关.
结论:
- 对ADHD的长期兴奋剂治疗对青少年和成人表面皮质厚度发展没有明显的影响.
- 观察到的依赖年龄的皮质厚度变化与典型的大脑发育的既定模式保持一致.
- 研究结果表明,兴奋剂治疗不会改变皮质厚度的发育轨迹.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Mania and Antimanic Drugs: Overview
